| Isolation and characterization of protective anti-LPS nanobody against V. cholerae O1 recognizing Inaba and Ogawa serotypes W Ebrahimizadeh, S Mousavi Gargari, M Rajabibazl, L Safaee Ardekani, ... Applied microbiology and biotechnology 97, 4457-4466, 2013 | 75 | 2013 |
| A novel nanobody against urease activity of Helicobacter pylori LS Ardekani, SLM Gargari, I Rasooli, MR Bazl, M Mohammadi, ... International Journal of Infectious Diseases 17 (9), e723-e728, 2013 | 61 | 2013 |
| In vivo neutralization of botulinum neurotoxins serotype E with heavy-chain camelid antibodies (VHH) H Bakherad, SL Mousavi Gargari, I Rasooli, M RajabiBazl, M Mohammadi, ... Molecular biotechnology 55, 159-167, 2013 | 59 | 2013 |
| Production of nanobodies against prostate-specific membrane antigen (PSMA) recognizing LnCaP cells H Zare, M Rajabibazl, I Rasooli, W Ebrahimizadeh, H Bakherad, ... The International journal of biological markers 29 (2), 169-179, 2014 | 45 | 2014 |
| Camelid‐derived heavy‐chain nanobody against Clostridium botulinum neurotoxin E in Pichia pastoris R Baghban, SLM Gargari, M Rajabibazl, S Nazarian, H Bakherad Biotechnology and applied biochemistry 63 (2), 200-205, 2016 | 41 | 2016 |
| Nanobodies, the potent agents to detect and treat the Coronavirus infections: A systematic review H Zare, H Aghamollaei, M Hosseindokht, M Heiat, A Razei, H Bakherad Molecular and Cellular Probes 55, 101692, 2021 | 27 | 2021 |
| Nanobodies: A tool to open new horizons in diagnosis and treatment of prostate cancer M Hosseindokht, H Bakherad, H Zare Cancer Cell International 21, 1-9, 2021 | 21 | 2021 |
| Outlook of therapeutic and diagnostic competency of nanobodies against SARS-CoV-2: a systematic review H Aria, F Mahmoodi, HS Ghaheh, H Zare, M Heiat, H Bakherad Analytical Biochemistry 640, 114546, 2022 | 18 | 2022 |
| Identification and in vitro characterization of novel nanobodies against human granulocyte colony-stimulating factor receptor to provide inhibition of G-CSF function H Bakherad, SLM Gargari, Z Sepehrizadeh, H Aghamollaei, RA Taheri, ... Biomedicine & Pharmacotherapy 93, 245-254, 2017 | 17 | 2017 |
| Isolation and characterization of a novel nanobody for detection of GRP78 expressing cancer cells H Aghamollaei, M Ghanei, MJ Rasaee, AM Latifi, H Bakherad, ... Biotechnology and Applied Biochemistry 68 (2), 239-246, 2021 | 12 | 2021 |
| Structure prediction, expression, and antigenicity of c‐terminal of GRP78 H Aghamollaei, SL Mousavi Gargari, M Ghanei, MJ Rasaee, J Amani, ... Biotechnology and applied biochemistry 64 (1), 117-125, 2017 | 12 | 2017 |
| Nanobodies; new molecular instruments with special specifications for targeting, diagnosis and treatment of triple-negative breast cancer H Bakherad, F Ghasemi, M Hosseindokht, H Zare Cancer Cell International 22 (1), 245, 2022 | 7 | 2022 |
| In silico and in vitro studies of thiosemicarbazone-indole hybrid compounds as potent α-glycosidase inhibitors Z Bakherad, H Bakherad, S Sepehri, MA Faramarzi, K Mahnam, ... Computational Biology and Chemistry 97, 107642, 2022 | 7 | 2022 |
| Design, synthesis, and in silico studies of tetrahydropyrimidine analogs as urease enzyme inhibitors N Ahangarzadeh, N Shakour, S Rezvanpoor, H Bakherad, MH Pakdel, ... Archiv der Pharmazie 355 (10), 2200158, 2022 | 6 | 2022 |
| Biochemical and molecular characterization of novel keratinolytic protease from Bacillus licheniformis (KRLr1) S Rahimnahal, A Meimandipour, J Fayazi, A Asghar Karkhane, ... Frontiers in Microbiology 14, 1132760, 2023 | 5 | 2023 |
| Emerging Technologies for the Treatment of COVID-19 H Aghamollaei, R Sarvestani, H Bakherad, H Zare, PC Guest, R Ranjbar, ... Clinical, biological and molecular aspects of COVID-19, 81-96, 2021 | 4 | 2021 |
| Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity H Bakherad, M Farahmand, N Setayesh, A Ebrahim-Habibi Life Sciences 257, 118052, 2020 | 4 | 2020 |
| Synthesis, biological assessment, and computational investigations of nifedipine and monastrol analogues as anti-leishmanial major and anti-microbial agents M Khalilzadeh, S Saberi, G Noori, M Vaziri, S Sepehri, H Bakherad, ... Molecular Diversity 27 (6), 2555-2575, 2023 | 3 | 2023 |
| Anti-EGFR bioengineered bacterial outer membrane vesicles as targeted immunotherapy candidate in triple-negative breast tumor murine model R Rezaei Adriani, SL Mousavi Gargari, H Bakherad, J Amani Scientific Reports 13 (1), 16403, 2023 | 2 | 2023 |
| Synthesis, Biological Activity Evaluation, Docking and Molecular Dynamics Studies of New Triazole‐Tetrahydropyrimidinone (thione) Hybrid Scaffolds as Urease Inhibitors S Rezvanpoor, N Shakour, N Ahangarzadeh, H Bakherad, S Sepehri, ... Chemistry & Biodiversity 20 (5), e202300054, 2023 | 1 | 2023 |
